RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000083.xml
Synlett 2018; 29(06): 793-798
DOI: 10.1055/s-0037-1609094
DOI: 10.1055/s-0037-1609094
letter
Synthesis of Optically Pure (S,E)-2-Amino-5-arylpent-4-enoic Acids by Heck Reactions of Nickel Complexes
Financial support by the State of Mecklenburg-Vorpommern, by the DAAD (Ostpartnerschaften program), and by the Volkswagenstiftung is gratefully acknowledged.Weitere Informationen
Publikationsverlauf
Received: 25. Oktober 2017
Accepted after revision: 26. November 2017
Publikationsdatum:
15. Januar 2018 (online)
Abstract
Starting from commercially available building blocks a variety of enantiomerically pure (S)-2-amino-4-enoic acids has been synthesized by the Heck reaction using Ni-(S)-BPB {Nickel-N-[(S)-benzylprolyl]aminobenzophenone} as a chiral auxiliary. The reactions proceeded in very good yields and with high E-selectivity.
Supporting Information
- Supporting information for this article is available online at https://doi.org/10.1055/s-0037-1609094.
- Supporting Information
-
References and Notes
- 1a Hatanaka S.-I. Niimura Y. Takishima K. Trans. Mycol. Soc. Jpn. 1985; 26: 61
- 1b Yamaura Y. Fukuhara M. Takabatake E. Ito N. Hashimoto T. Toxicology 1986; 38: 161
- 2 Dittmer K. Goodman I. Stanley JC. J. Am. Chem. Soc. 1948; 70: 2499
- 3a Alberici de Canal M. Rodríguez De Lores Arnaiz G. De Robertis E. Biochem. Pharmacol. 1969; 18: 137
- 3b Abshire VM. Hankins KD. Roehr KE. Dimicco JA. Neuropharmacology 1988; 27: 1171
- 3c Sajdyk TJ. Johnson PL. Fitz SD. Shekhar A. J. Psychopharmacol. 2008; 22: 633
- 4a Manning PT. Connor JR. Seibert K. Rao CV. Reddy BS. US 200313702, 2003
- 4b Beams RM. Hodson HF. Palmer RM. J. US 5863931, 1999
- 4c Gapud RE. Hagen TJ. Hallinan EA. Hansen DW. Jr. Pitzele BS. Metz SS. Webber RK. Tjoeng FS. Manning RE. Toth MV. US 6207708, 2001
- 4d Pitzele BS. Sikorski JA. Webber RK. US 200277363, 2002
- 5 Attwood MR. Hurst DN. Jones PS. Kay PB. Raynham TM. Wilson FX. US 5866684, 1999
- 6 Liu H. Tully D. Epple R. Bursulaya B. Williams J. Chatterjee A. Harris JL. Li J. US 2004198780, 2004
- 7a Karrer P. Itschner V. Helv. Chim. Acta 1935; 18: 782
- 7b Fillman J. Albertson N. J. Am. Chem. Soc. 1948; 70: 171
- 7c Albertson NF. J. Am. Chem. Soc. 1951; 73: 452
- 7d Schlögl K. Monatsh. Chem. 1958; 89: 377
- 8a Broxterman QB. Kaptein B. Kamphuis J. Schoemaker HE. J. Org. Chem. 1992; 57: 6286
- 8b Rutjes FP. J. T. Veerman JJ. N. Meester WJ. N. Hiemstra H. Schoemaker HE. Eur. J. Org. Chem. 1999; 1127
- 9a Duthaler RO. Tetrahedron 1994; 50: 1539
- 9b Weiner B. Szymański W. Janssen DB. Minnaard AJ. Feringa BL. Chem. Soc. Rev. 2010; 39: 1656
- 10 Nun P. Pérez V. Calmès M. Martinez J. Lamaty F. Chem. Eur. J. 2012; 18: 3773
- 11 Qiu W. Soloshonok VA. Cai C. Tang X. Hruby VJ. Tetrahedron 2000; 56: 2577
- 12a Belokon’ YN. Kochetkov KA. Churkina TD. Ikonnikov NS. Orlova SA. Smirnov VV. Chesnokov AA. Mendeleev Commun. 1997; 7: 137
- 12b Kozísek J. Fronc M. Skubák P. Popkov A. Breza M. Fuess H. Paulmann C. Acta Crystallogr., Sect. A: Found. Crystallogr. 2004; 60: 510
- 12c Popkov A. Transition Met. Chem. 2003; 28: 475
- 12d Ellis TK. Ueki H. Soloshonok VA. Tetrahedron Lett. 2005; 46: 941
- 13a Soloshonok VA. Cai C. Hruby VJ. Tetrahedron: Asymmetry 1999; 10: 4265
- 13b Soloshonok VA. Cai C. Hruby VJ. van Meervelt L. Yamazaki T. J. Org. Chem. 2000; 65: 6688
- 14 Soloshonok VA. Avilov DV. Kukhar VP. van Meervelt L. Mischenko N. Tetrahedron Lett. 1997; 38: 4671
- 15a Soloshonok VA. Avilov DV. Kukhar’ VP. Tararov VI. Savel’eva TF. Churkina TD. Ikonnikov NS. Kochetkov KA. Orlova SA. Pysarevsky AP. Struchkov YT. Raevsky NI. Belokon’ YN. Tetrahedron: Asymmetry 1995; 6: 1741
- 15b Soloshonok VA. Kukhar VP. Galushko SV. Svistunova NY. Avilov DV. Kuz’mina NA. Raevski NI. Struchkov YT. Pysarevsky AP. Belokon YN. J. Chem. Soc., Perkin Trans. 1 1993; 3143
- 16 Sorochinsky AE. Aceña JL. Moriwaki H. Sato T. Soloshonok VA. Amino Acids 2013; 45: 691
- 17 Parpart S. Petrosyan A. Shah SJ. A. Adewale RA. Ehlers P. Grigoryan T. Mkrtchyan AF. Mardiyan ZZ. Karapetyan AJ. Tsaturyan AH. Saghyan AS. Iqbal J. Langer P. RSC Adv. 2015; 5: 107400
- 18a Heck RF. Org. React. 1982; 27: 345
- 18b de Meijere A. Meyer FE. Angew. Chem., Int. Ed. Engl. 1994; 33: 2379
- 18c Beletskaya IP. Cheprakov AV. Chem. Rev. 2000; 100: 3009
- 19a Belokon YN. Bakhmutov VI. Chernoglazova NI. Kochetkov KA. Vitt SV. Garbalinskaya NS. Belikov VM. J. Chem. Soc., Perkin Trans. 1 1988; 305
- 19b Soloshonok V. Boettiger T. Bolene S. Synthesis 2008; 2594
- 19c Nádvorník M. Langer V. Jirásko R. Holčapek M. Weidlich T. Lyčka A. Popkov A. Polyhedron 2008; 27: 3477
- 20a Belokon YN. Chernoglazova NI. Kochetkov CA. Garbalinskaya NS. Belikov VM. J. Chem. Soc., Chem. Commun. 1985; 3: 171
- 20b Soloshonok VA. Belikov VM. Kuz’mina NA. Maleev VI. Svistunova NY. Solodenko VA. Kukhar’ VP. J. Chem. Soc., Perkin Trans. 1 1992; 1525
- 20c Soloshonok VA. Belokon YN. Kukhar VP. Chernoglazova NI. Saporovskaya MB. Bakhmutov VI. Kolicheva MT. Belikov VM. Izv. Akad. Nauk SSSR, Ser. Khim. 1990; 1930
- 21 (S,E)-2-Amino-2-methyl-5-[phenyl]pent-4-enoic acid–Ni–(S)-BPB (3a) Compound 2b (221 mg, 1.0 equiv), Pd(PPh3)4(23 mg, 0.05 equiv), and bromobenzene (72 μl, 1.7 equiv) were added to a pressure tube and dissolved in 1,4-dioxane (6 ml, 15 l/mol 2b) and HN i Pr2 (6 mL, 15 l/mol 2b). The mixture was stirred at 101 °C for 24 h. After cooling to room temperature it was diluted with ethyl acetate and washed with water. The organic layer was dried with Na2SO4 and filtered. The solvent was removed under reduced pressure, and the residue was purified by silica column chromatography (ethyl acetate/heptanes, 2:1 >> 1:0) to yield 3a as a red solid; yield 88%, mp 112–113 °C. 1H NMR (250 MHz, CDCl3): δ = 1.27 (s, 3 H, CH3), 1.35–1.74 (m, 1 H, CH2), 1.82–1.99 (m, 1 H, CH2), 2.01–2.25 (m, 2 H, CH2), 2.48–2.73 (m, 3 H, CH2), 3.27 (dd, 3 J = 9.8 Hz, 3 J = 7.1, 1 H, CH), 3.42–3.55 (m, 1 H, CH2), 3.61 (d, 2 J = 12.7 Hz, 1 H, CH2Ph), 4.40 (d, 2 J = 12.7 Hz, 1 H, CH2Ph), 6.58–6.74 (m, 3 H, CH), 6.85–7.00 (m, 1 H, CH), 7.03–7.19 (m, 2 H, CH), 7.21–7.57 (m, 11 H, CH), 7.61–7.74 (m, 1 H, CH), 7.96–8.10 (m, 3 H, CH). 13C NMR (63 MHz, CDCl3): δ = 23.1 (CH3), 29.7, 30.7, 43.9, 63.6 (CH2), 70.2 (CH), 78.7 (C), 120.9, 124.0, 124.2, 126.8, 127.2, 127.7, 128.0, 128.3 (CH), 128.7 (C) 128.8, 129.0, 129.1, 129.7, 130.8, 131.9 (CH), 133.5 (C), 133.7, 134.7 (CH), 136.8, 137.3, 142.0 (C), 172.8 (C=N), 180.7 (C=O), 181.9 (C=O). IR (ATR): ν = 3057 (w), 3025 (w), 2922 (br, w), 2867 (w), 1668 (m), 1634 (s), 1594 (w), 1574 (w), 1534 (w), 1495 (w), 1469 (w), 1436 (m), 1355 (s), 1331 (m), 1312 (w), 1287 (w), 1250 (s), 1163 (m), 1118 (w), 1062 (w), 1000 (w), 964 (m), 927 (w), 885 (w), 824 (w), 748 (s), 695 (s), 618 (w), 563 (w), 540 (m) cm–1. MS (EI, 70 eV): m/z (%) = 627 (5) [M+], 585 (15), 584 (13), 583 (32), 510, (7), 492 (4), 440 (4), 439 (4), 425 (4), 347 (1), 328 (2), 280 (2), 278 (2), 161 (9), 160 (89). ESI-HRMS: m/z calcd for C37H36N3NiO3 [M + H+]: 628.21047; found: 628.20997; m/z calcd for C37H36N3 60NiO3 [M + H+]: 630.20798; found: 630.20805; m/z calcd for C37H35N3NiNaO3 [M + Na+]: 650.19241; found: 650.19232; m/z calcd for C37H35N3Na60NiO3 [M + Na+]: 652.18992; found: 652.18952.
- 22 (S,E)-2-Amino-2-methyl-5-[phenyl]pent-4-enoic acid (4a) Compound 3a (190 mg, 1.0 equiv) was dissolved in MeOH/H2O (10 ml/5 ml), and HCl (12 M, 1.5 ml) was added dropwise. The stirred mixture was heated to reflux for 20 min (during which time the color changed from red to green). After cooling to room temperature the mixture was diluted with water and extracted with DCM four times. The aqueous layer was treated with 5% aq NH3solution to reach pH 2. The solution was further purified by cation exchange column (Dowex 50WX8 H+, see Supporting Information for details) to yield 4a as white solid; yield 85%, mp 267–268 °C. 1H NMR (300 MHz, CD3OD): δ = 1.64 (s, 3 H, CH3), 2.79 (dd, 3 J = 7.6 Hz, 2 J = 14.5 Hz, 1 H, CH2), 2.87 (dd, 3 J = 7.6 Hz, 2 J = 14.5 Hz, 1 H, CH2), 6.21 (dt, 3 J = 7.6 Hz, 3 J = 15.4 Hz, 1 H, C=C), 6.65 (d, 3 J = 15.4 Hz, 1 H, C=C), 7.19–7.34 (m, 3 H, Ph), 7.40–7.45 (m, 2 H, Ph). 13C NMR (75 MHz, CD3OD): δ = 22.7 (CH3), 41.8 (CH2), 61.2 (C), 121.8 (CH), 127.7, 129.1, 129.7, 137.8 (CH), 138.1 (C), 173.5 (COOH). IR (ATR): ν = 3000 (br, m), 1656 (br, w), 1540 (w), 1573 (s), 1494 (w), 1450 (w), 1397 (s), 1366 (m), 1287 (w), 1264 (w), 1239 (w), 1130 (w), 1070 (w), 965 (s), 883 (w), 788 (w), 739 (s), 690 (s), 629 (w), 587 (w), 553 (w) cm–1. MS (EI, 70 eV): m/z (%) = 206 (4), 205 (2) [M+], 194 (5), 193 (13), 178 (4), 161 (6), 160 (64), 159 (12), 144 (12), 143 (16), 129 (13), 128 (34), 118 (31), 117 (87), 116 (50), 115 (86), 102 (12), 91 (60), 90 (6), 89 (42), 88 (100), 80 (16), 77 (15), 65 (13), 63 (11). HRMS (EI): m/z calcd for C12H16NO2 [M + H+]: 206.11756; found: 206.11778.
For reviews about chiral amino acid syntheses, see: